scholarly journals PREVALENCE OF TOXOPLASMOSIS AMONG SHEEP AND GOATS IN BAGHDAD AREA

2021 ◽  
Vol 22 (1) ◽  
pp. 43-49
Author(s):  
Layla Kh.Rifaat ◽  
Suad Z.Jawdat

The complement fixation test (CFT) and the direct fluorescent antibody test were used for detecting anti Toxoplasma gondii antibodies in sera obtained from 143 sheep and 44 goats. Complement fixing antibodies were detected in 38 (26.2%) for sheep sera and 24 (54.5%) of goat sera tested by CFT.  On the other hand, 26(18.2%) of sheep sera were positive by the FAT. The combined use of CFT and FAT allows the differentiation between an acute or latent T.gondii infection.

1962 ◽  
Vol 8 (4) ◽  
pp. 545-554 ◽  
Author(s):  
A. E. Kelen ◽  
L. Ayllon-Leindl ◽  
N. A. Labzoffsky

The principle of the indirect fluorescent antibody-staining procedure was adapted for use in the serodiagnosis of toxoplasmosis and the technique compared with other serological tests most commonly employed at present.The results obtained with normal and immune rabbit sera as well as human patients' sera indicate that the indirect fluorescent antibody test for toxoplasmosis is specific in a degree comparable to the complement fixation test, and is sensitive enough for routine laboratory use, its sensitivity being somewhat higher than that of the complement fixation test. The Sabin–Feldman dye test gave positive results with human sera from cases clinically unrelated to toxoplasmosis much more frequently and usually in higher titers than did the complement fixation and the fluorescent antibody tests. On the other hand, the dye test showed a few negative results on sera for which the other tests proved to be positive. The indirect fluorescent antibody test for toxoplasmosis is safer and simpler to perform than the dye test, as living organisms are not used in the test, and prepared smears of killed toxoplasma suspension on cover slips can be kept antigenically active in the frozen state for at least 6 months.The indirect fluorescent antibody test for toxoplasmosis is recommended for use in the serodiagnosis of toxoplasmosis either as a single test or as a supplementary test for checking complement fixation negative sera or the results obtained by the dye test.


2014 ◽  
Vol 17 (4) ◽  
pp. 607-612 ◽  
Author(s):  
B.A. Bażanów ◽  
A.B. Frącka ◽  
N.A. Jackulak ◽  
Z.M. Staroniewicz ◽  
S.M. Ploch

Abstract The purpose of the present review was a comparison of the abortions caused by EAV and EHV-1 viruses over the 34 years. A total of 452 tissues samples from aborted fetuses (347) or foals (105) stillborn or newborn that died within 72 hours were investigated. The material for the examinations came from different farms located throughout Poland. The tissue homogenates were examined by using virus isolation test in RK-13 and Vero cell lines and the cytopathic agent was confirmed as EHV-1 by the direct fluorescent antibody test or as EAV by the indirect fluorescent antibody test. The study indicated that EAV was isolated (104 cases, 23%) almost as equally often as EHV-1 (116 cases, 25.6%). Both, equid herpesvirus-associated abortion and the abortion induced by EAV were characterized by cyclicity. The percentage of EAV and EHV-1 isolation alternately reduced and increased, but the increase of isolation of one virus was accompanied by the decrease of the other. The domination of one virus over the other occurred in cycles of a few years.


1993 ◽  
Vol 4 (1) ◽  
pp. 43-46 ◽  
Author(s):  
Laila Sekla ◽  
Walter Stackiw ◽  
Gudrun Eibisch ◽  
Donna Kolton

Objectives: To report an epidemic ofMycoplasma pneumoniaein Manitoba and to discuss the limitations of the serodiagnostic tests used.Design: A retrospective analysis of the results of a province-wide serological testing for respiratory infections caused byM pneumoniae,using a complement fixation test and an indirect immunofluorescent antibody test for the detection of immunoglobulin (Ig) M antibodies.Material: From April 1, 1987, to March 31, 1991, 12,804 sera were tested and a serological diagnosis of recentM pneumoniaeinfections were established in 509 (3.97%). From April 1 to September 30, 1991, an additional 2088 persons were tested; the 158 (7.5%) recent cases ofM pneumoniaewere subjected to analysis.Results: Compared with the previous three years, an increase in the number of recent cases ofM pneumoniaewas first noticed in July 1990 which persisted until September 1991. Of 856 single sera tested, 59 (6.8%) were recentM pneumoniaeinfections and 56 (96.1%) of these were positive for IgM antibodies. Of the 616 persons who submitted paired sera, 99 (16%) were recent infections, but only 46 (46.4%) had IgM antibodies. Primary infections (ie, positive for IgM antibodies) were detected in 102 (64.5%) and reinfections (ie, positive complement fixation test only) in the remaining 56 persons with recentM pneumoniaeinfections. Primary infections were detected more frequently in the ‘under 16’ than in the ‘over 16’ year age group (75% versus 55.8% of the recent cases ofM pneumoniaein each age group). Reinfections were more common in the older age group. Of the 158 recent cases ofM pneumoniae,30.3% had a pneumonia; of these, 21 (55.2%) were under the age of 16 years.Discussion:M pneumoniaeis an important cause of morbidity. Serological tests are used for the diagnosis despite their limitations. The detection of IgM antibodies in acute serum establishes a diagnosis of primaryM pneumoniae;however, their absence does not excludeM pneumoniae. Asecond (convalescent) blood test is required to diagnose all primary infections. To diagnose all reinfections, paired sera should be tested by complement fixation.Summary: Manitoba experienced an epidemic ofM pneumoniaein 1990–91. Properly selected serological tests can provide a specific and rapid diagnosis.


1945 ◽  
Vol 81 (1) ◽  
pp. 119-135 ◽  
Author(s):  
John F. Enders ◽  
Sidney Cohen ◽  
Lewis W. Kane

1. A specific antibody, demonstrable by the technique of complement fixation, regularly appears, or increases in concentration, in the sera of human beings during an attack of mumps or during convalescence. 2. Specific dermal hypersensitivity, demonstrable by the injection of heat-inactivated mumps virus, has been shown to develop in 6 human beings after recovery from mumps. 3. Complement-fixing antibody and the hypersensitive state also emerge as a result of clinically inapparent infection with the virus of mumps. 4. These two phenomena are apparently unrelated in respect to immunologic mechanisms. 5. The data presented indicate that the complement fixation test should prove of value both in diagnosis and in the determination of immunity. 6. The skin test for dermal hypersensitivity, on the other hand, becomes positive after recovery and therefore would appear to be useful only as an index of resistance.


1952 ◽  
Vol 21 (3) ◽  
pp. 391-399 ◽  
Author(s):  
Elwood Buchman ◽  
Harold J. Kullman ◽  
George F. Margonis

1969 ◽  
Vol 62 (1_Suppl) ◽  
pp. S113-S133 ◽  
Author(s):  
Sam Brody

ABSTRACT This report is a summary of 10 years of experience with the complement fixation test as adopted for the immunoassay of HCG in serum. It is based on published as well as unpublished material. The discussion centers mainly around methodological problems, criteria of reliability, and clinical observations. It is our impression that the complement fixation test is a reasonably rapid and simple technical procedure. It is standard practice in every bacteriological and virological laboratory. The precision of the HCG assay is high. Its accuracy is good. The complement fixation assay, as reported here, fulfils the criteria of specificity. It has been evaluated by means of serological techniques and through comparison between biopotency and immunopotency of HCG in serum with reference to a common standard. Its application for routine as well as research work is illustrated.


Sign in / Sign up

Export Citation Format

Share Document